- Home
- USCB vs RNAC Comparison
USCB vs RNAC Comparison
Compare USCB & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USCB
- RNAC
- Stock Information
- Founded
- USCB 2002
- RNAC 2007
- Country
- USCB United States
- RNAC United States
- Employees
- USCB N/A
- RNAC N/A
- Industry
- USCB Major Banks
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- USCB Finance
- RNAC Health Care
- Exchange
- USCB Nasdaq
- RNAC Nasdaq
- Market Cap
- USCB 316.4M
- RNAC 276.3M
- IPO Year
- USCB 2021
- RNAC 2016
- Fundamental
- Price
- USCB $17.34
- RNAC $10.05
- Analyst Decision
- USCB Buy
- RNAC Strong Buy
- Analyst Count
- USCB 3
- RNAC 4
- Target Price
- USCB $20.33
- RNAC $40.00
- AVG Volume (30 Days)
- USCB 16.8K
- RNAC 48.4K
- Earning Date
- USCB 07-24-2025
- RNAC 08-07-2025
- Dividend Yield
- USCB 2.30%
- RNAC N/A
- EPS Growth
- USCB 67.08
- RNAC N/A
- EPS
- USCB 1.47
- RNAC N/A
- Revenue
- USCB $88,094,000.00
- RNAC $1,026,000.00
- Revenue This Year
- USCB $26.38
- RNAC N/A
- Revenue Next Year
- USCB $4.39
- RNAC N/A
- P/E Ratio
- USCB $11.83
- RNAC N/A
- Revenue Growth
- USCB 32.06
- RNAC N/A
- 52 Week Low
- USCB $13.85
- RNAC $8.46
- 52 Week High
- USCB $21.86
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- USCB 55.15
- RNAC 34.71
- Support Level
- USCB $17.10
- RNAC $10.50
- Resistance Level
- USCB $17.98
- RNAC $11.80
- Average True Range (ATR)
- USCB 0.52
- RNAC 0.56
- MACD
- USCB 0.06
- RNAC -0.11
- Stochastic Oscillator
- USCB 73.38
- RNAC 0.45
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.